Correlation Between AN2 Therapeutics and ELYM Old
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and ELYM Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and ELYM Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and ELYM Old, you can compare the effects of market volatilities on AN2 Therapeutics and ELYM Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of ELYM Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and ELYM Old.
Diversification Opportunities for AN2 Therapeutics and ELYM Old
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between AN2 and ELYM is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and ELYM Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ELYM Old and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with ELYM Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ELYM Old has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and ELYM Old go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and ELYM Old
Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the ELYM Old. In addition to that, AN2 Therapeutics is 1.04 times more volatile than ELYM Old. It trades about -0.02 of its total potential returns per unit of risk. ELYM Old is currently generating about 0.02 per unit of volatility. If you would invest 362.00 in ELYM Old on October 16, 2024 and sell it today you would lose (53.00) from holding ELYM Old or give up 14.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.14% |
| Values | Daily Returns |
AN2 Therapeutics vs. ELYM Old
Performance |
| Timeline |
| AN2 Therapeutics |
| ELYM Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
AN2 Therapeutics and ELYM Old Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and ELYM Old
The main advantage of trading using opposite AN2 Therapeutics and ELYM Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, ELYM Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ELYM Old will offset losses from the drop in ELYM Old's long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |